SAN DIEGO, Feb. 15, 2018 -- Pets around the country are being sent off to see their veterinarians to score pills for their owners, and states around the country and trying to find out what they can do to stop it. Drug news provider The Recover has a new story released about Arkansas’ new addition to the Prescription Drug Monitoring Program, as of August 2017. Veterinarians are now being asked to check the program before prescribing certain abused medications as to see if a pet’s owner is known for pill abuse.
|
|||||
Some specialists are even refusing to send out medications with owners, and do not fill any prescriptions except within their own property. Others are switching out patches for pills as an alternative that is less likely to be abused. The most commonly abused drugs are Tramadol, which is a prescription oral drug used to treat moderate to severe pain, and Xanax, which is commonly used for anxiety.
Not all veterinarians agree that they have an impact on the opioid crisis, and state that they have an unlikely involvement in the outcome of prescriptions being abused. Maine Veterinary Medical Association acknowledges the crisis, saying “opioid epidemic is a serious public health crisis that requires all prescribers and dispensers of opioids and benzodiazepines to assist in preventing the misuse or diversion of these drugs,” veterinarians “are ineffective participants in reducing drug abuse by the public” because they “do not have the human medical exposure or background to review medical prescription information for animal owners.”
But others are on the side of whatever can help, they support. Dr. David Gurzak, a family vet at Brackett Street Veterinary Clinic in Portland, Maine, says, “Practically speaking, it’s hard to prove this is making a big difference. But it’s such a terrible crisis, what’s happening,” he added. “So whatever avenues we pursue to avoid the diversion of drugs is good idea in my book.”
Author: Kevin Leonard
Organization: TheRecover.com
Address: 27420 Jefferson Ave, Temecula, CA 92590
Phone: 888-510-3898
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/f2ba0c79-f41e-40d1-bedf-6e2b35a9a937


U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
How Marco Pharma International Preserves German Homeopathic Traditions in America
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
FTC Questions Apple News Over Alleged Bias Against Conservative Media
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence 



